- MeSH
- Marijuana Abuse pathology MeSH
- Alcoholism pathology MeSH
- Hallucinogens adverse effects MeSH
- Humans MeSH
- Methamphetamine adverse effects MeSH
- Narcotics adverse effects MeSH
- Aftercare MeSH
- Behavior, Addictive MeSH
- Personal Narratives as Topic MeSH
- Substance-Related Disorders MeSH
- Psychotherapy MeSH
- Psychotropic Drugs classification adverse effects MeSH
- Sexuality * MeSH
- Social Work classification manpower MeSH
- Social Workers education MeSH
- Drug Users * MeSH
- Dependency, Psychological MeSH
- Heroin Dependence pathology MeSH
- Check Tag
- Humans MeSH
- MeSH
- Alcoholism rehabilitation therapy MeSH
- Art Therapy * MeSH
- Aftercare utilization MeSH
- Behavior, Addictive rehabilitation therapy MeSH
- Substance-Related Disorders rehabilitation therapy MeSH
- Psychotherapy methods MeSH
- Social Isolation MeSH
- Social Welfare MeSH
- Symbolism * MeSH
- Dependency, Psychological MeSH
Cílem příspěvku je informovat čtenáře o novém postupu ambulantní práce s lidmi závislými na stimulačních drogách (kokain, crack, pervitin). Nová metodika práce s názvem Krátký intervenční program je využívána ve Velké Británii. V rámci spolupráce s britskou společností Rugby House, která je garantem zmíněné metodiky, bude program přepracován pro uživatele pervitinu, následně bude v průběhu tří let vyhodnocována jeho úspěšnost. Výsledkem práce bude nová metodika s názvem Krátký intervenční program pro uživatele pervitinu.
The goal of this report is to provide information about a new approach to the outpatient treatment of people addicted to stimulant drugs such as cocaine, crack, and pervitin. A new approach involving a brief intervention programme has been implemented in the UK. This methodology was developed by Aidan Gray of Rugby House, London. On the basis of cooperation between P-centrum Olomouc and Rugby House London, we would like to use this methodology in the Czech Republic. The programme was primarily designed for persons addicted to cocaine and crack. We intend to adapt it for users of pervitin in the Czech Republic. During a three-year period we will evaluate the programme to ascertain its effectiveness. The outcome of our work will be the Pervitin Use Brief Intervention Programme. The article describes the experience of pervitin users only. Therefore, it is not possible to generalise all the information presented in this article or apply it to the drug user population as a whole.
